Domestic refined oil retail market recently renewed waves.

Reporters learned from the industry, by the petrochemical, PetroChina two main units led by a round of price cuts are more gas stations staged, private, social stations forced to follow up, which triggered a fierce market share battle.

In the industry view, this is the domestic refined oil supply, demand downturn, retail high profits and even share the popularity of multiple factors such as cycling. In addition, it does not rule out the sale of Sinopec in the overseas IPO before the outbreak of sales.

More gas and diesel prices war started

“From the beginning of May, Sinopec and PetroChina gas station gasoline and diesel retail price war quietly started, preferential rates unprecedented, most in the 1 yuan per liter to 1.5 yuan, of which, Shandong, Henan, Zhejiang, Guangdong and other regions of the price war Bigger. “Industry agencies Jinlian a product analyst Wang Yanting yesterday on the card reporter said.

Reporters learned from Sinopec, the group’s Jiangsu oil branch recently jointly Jiangsu Agricultural Machinery Bureau, launched the “farming farming farmers” a number of initiatives for hundreds of thousands of agricultural machinery to provide a range of about 10% price concessions.

In addition, the Texas Agricultural Machinery Bureau and Sinopec and Texas Petrochemical Company recently jointly studied and developed a “three summer” agricultural machinery for the benefit of agricultural policy: June 1 to June 15 period, the city’s 84 gas stations 0 Diesel premium per liter limit of 1 yuan.

Sinopec Anhui Chizhou Oil Company in the urban area of ​​several large gas stations to implement the “peak peak refueling concessions” activities, the discount rate of about 0.3 yuan per liter. Statistics show that the implementation of the peak peak refueling, the average daily sales of 95 gasoline increased by about 20%, the highest growth of 39.8%.

It is understood that Shandong Zibo part of the recent petrochemical petrol station has been the preferential efforts to reach 1.2 yuan / liter, in some of the more intense competition even more 2.3 yuan / liter discount rate. The PetroChina gas station is also “not far behind”, have hit price ads to attract customers.

For example, PetroChina Zhumadian branch of the gas station launched No. 0 diesel prices straight down concessions; Fujian PetroChina-owned gas stations are launched micro-credit to pay the random reduction and other preferential measures.

It is noteworthy that this is Sinochem for many years to take the initiative to join the sales price of refined oil war, and the preferential range, for a long time. In the past, as the domestic refined oil retail boss Sinopec by virtue of the gas station network, oil quality and other advantages, rarely involved in the private fuel station led by the price war.

Multiple factors agitated oil retail market

“This is the result of increasing domestic refinery production capacity.” Wang Yanting told reporters that as of now the domestic refinery production capacity has exceeded 800 million tons, refined oil supply rose sharply, but by the downturn in the market constraints, the overall performance of downstream demand is not optimistic. The imbalance between supply and demand makes the retail market feel pressure.

She said that in 2017, the main unit retail market sales were significantly landslide, increase sales efforts is to increase sales, to seize market share one of the effective ways.

With the high temperature weather struck, outdoor operations are affected, and this year’s fishing moratorium and more than a month in advance, which have inhibited the demand for diesel. On the other hand, the popularity of shared bicycles also has a negative impact on gasoline consumption.

At the same time, the current retail links are in the golden period of high profits, making oil prices larger space. According to Jin Lianchuang monitoring, in May the domestic 92 gasoline theoretical retail profits roughly 1906 yuan / ton, diesel theory, the retail profit of roughly 1456 yuan / ton, the petrol station considerable profits. Despite the increasing efforts to increase, but still profitable.

Another broker is not willing to name the broker told reporters that the background of the price war is the first domestic gasoline demand for the cumulative year-on-year growth rate for the first time negative, significantly different from the past few years apparent demand growth of about 10% The normal state. Gas demand growth is expected in the next few years will be the next step, so that the pressure of domestic oil excess oil growing. Second, to refining the right to use crude oil last year after the release of raw materials from the shackles, a substantial increase in operating rate, which also makes the market flow of refined oil increased, the impact of the market. In addition, the spread of domestic and foreign Guangdong Fujian coastal oil smuggling has become one of the factors affecting the balance of supply and demand of refined oil.

In his view, with the private refineries in the next few years of large-scale production, domestic oil surplus will be more serious.

“As far as we know, Sinopec’s price war has successfully squeezed the share of some social gas stations, resulting in the latter last month sales fell by nearly 40% .Through this round of price war, Sinopec to let everyone see its gas station in the brand service , The absolute advantage of the regional position, but also people see the ‘two barrels of oil’ is not a big bad boat, not not able to participate in market competition, proved its sales strategy can be more flexible. “The researcher said.

He also said that the price does not rule out and Sinopec sales company in the overseas IPO overnight sales related.

From April 2017 published in the new drug registration related policies and data can be seen, CFDA tilt of new drugs to increase imports of new drugs and major domestic new drugs are CFDA to speed up the review and approval of the focus, and also reflected in the self-examination Verification progress. According to this analysis, imports of new drugs in 2017 will lead to changes in market structure.

The author summarizes the policies and data on the registration of new drugs published in April 2017, explores the intrinsic relationship between the import of the imported drugs, the listing of the first drugs and the priority review, the consistency evaluation and the self-examination and verification, and find the market under the new pattern Trend and project direction.

Two new hepatitis C drugs approved

April 28, CFDA issued a new drug listing announcement, has approved the United States and the United States and China Shibao Po (China) Investment Co., Ltd. of dalazapir hydrochloride tablets and A Shu Ruwei soft capsule market, mainly for adult chronic hepatitis C combination therapy The

Recalling the registration process of two products, darazapril hydrochloride tablets and Ashu Ruiwei soft capsules are priority to review the product. In February 2016, dalazavir hydrochloride tablets and Ashu Ruiwei soft capsule were reported clinically; in November 2016, at the same time, in the fourth batch of clinical self-examination checklist and No. 8 drug clinical trial data on-site verification plan, the month Declaration of production; in December 2016, the production of two products are accepted in the fifth batch of clinical self-examination checklist, but none of the published clinical trials in any of the clinical data test plan.

It is reported that follow-up CFDA will continue to speed up the review of oral direct anti-hepatitis C virus drugs to promote the listing of such drugs.

Priority review into a major new drug

April 27, CDE published “to be included in the priority review process drug registration application of the publicity (the sixteenth batch)” only Zhengda Tianqing Pharmaceutical and Lianyungang Runzhong pharmaceutical declaration of azulodin hydrochloride capsules and APIs The The reason why the drug is included in the proposed priority review process is “significant treatment advantages compared with existing treatment”; There are also reasons for the inclusion of the “major project” for the priority review process

Beads were injected with sodium iloprazole sodium and iloprazole sodium, but eventually failed to enter the “included in the list of priority review varieties”.

Import a large number of new drugs approved, the market pattern changes

2017 CFDA “on the adjustment of import drug registration matters related to the decision (draft)” comments issued after the announcement of the import of drugs approved to speed up. And from the sixth batch, the import drug acceptance number accounted for the number of self-check acceptance number dropped significantly. Delta data V3.2 found that imports of new drugs in 2017 will lead to changes in market structure.

The first is the hepatitis C drug market, in addition to Bristol-Myers Squibb (China) Investment Co., Ltd. approved two new drugs, there is to declare the listing of the Kyrgyz Yusuo Pupuowei film also entered the sixth batch of self-examination list, the admissibility Is also listed on the CDE “Priority list” and is expected to be available in the second half of 2017. Thus, has been confirmed in Europe and the United States significant efficacy of hepatitis C new drug battle, will be officially staged in China, who is expected to take the lead in China’s health insurance negotiations directory who is more likely to win.

Tyrosine kinase inhibitors, the oseltidomethanesulfonate tablets approved after 2016 were indications of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR T790M mutation positive Treatment, alfanitine maleate indications for the treatment of epidermal growth factor receptor (EGFR) mutations in locally advanced or metastatic NSCLC patients. The active treatment of myelofibrosis and polycythemia vera is the main treatment of irinodipine phosphate. NSCLC drug market competition is expected to intensify in 2017. Diabetes drug market in 2017 there will be a new change. Glucagon-like peptide 1 (GLP-1) receptor agonists, it is expected that risperidone injection is expected to be approved in 2017. Sodium-glucose synergistic transporter 2 (SGLT2), the new batch was approved in 2017, and it is expected that the tablets will be approved soon. (Ⅰ) (II), and the first batch of self-checklist pending the listing of salatrine-metformin sustained-release tablets (Ⅰ) (II) and (III), the sixth batch of self-checklist in the Engler net hydrochloric acid metformin tablets.

(I) (II) and (III), and telmisartan amlodipine tablets are expected to be available in the second half of 2017.

Self-examination of the sixth batch: oral generic drug began to review?

In the sixth batch of self-examination check list, the only one in the list of priority review of the product is the stone medicine group Ouyi Pharmaceutical Co., Ltd. metformin hydrochloride tablets, selected for the “same production line production, has been listed in the United States, Apply for domestic generic drugs listed. ” I believe that stone powder metformin hydrochloride tablets once approved by means of consistency assessment. In addition to metformin hydrochloride tablets, montelukast chewable tablets, benzoylate soft capsules, tramadol hydrochloride tablets, donepezil hydrochloride tablets and metformin hydrochloride sustained-release tablets are approved in the United States ANDA.

In the fight for the first drug imipramine tablets, lenalidomide capsules, vildagliptin tablets, erlotinine hydrochloride tablets, moxifloxacin hydrochloride tablets, pramipine hydrochloride tablets and paclitaxel for injection (albumin Combination type).

Among them, lenalidomide capsules, the first batch of self-examination involved in Beijing Shuanglu Pharmaceutical Co., Ltd. products have not yet approved, Zhengda Tianqing Pharmaceutical Group Co., Ltd. products have been in the sixth batch of self-check list Line up. Moxyche hydrochloride tablets, the first batch of self-examination of the company have Chongqing Winbond Pharmaceutical Co., Ltd., Jiangsu Tianyi Pharmaceutical Co., Ltd. and Beijing Wansheng Pharmaceutical Co., Ltd., the fourth batch of self-examination involved in Peking University Pharmaceutical Co., Ltd. , The sixth batch of self-examination involving the Stone Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. and Nanjing Xingang Pharmaceutical Co., Ltd., which has been withdrawn involving Chongqing Winbond Pharmaceutical Co., Ltd. and Jiangsu Tianyi Pharmaceutical Co., Ltd.

to sum up

From April 2017 published in the new drug registration related policies and data can be seen, CFDA tilt of new drugs to increase imports of new drugs and major domestic new drugs are CFDA to speed up the review and approval of the focus, and also reflected in the self-examination Verification progress. Hepatitis C, cancer, diabetes and high blood pressure will be the areas most affected by this policy.

Domestic first imitation competition

In the second half of 2017 is expected to restart, cardiovascular, cancer and diabetes medication is also the main competition of domestic enterprises.

Consistency evaluation Project competition is also expected to start in the second half of 2017, the same production line in Europe and the United States simultaneously listed products will be expected to obtain priority review, but the record system shorten the registration time, the time between enterprises is not too much time to be approved. It is expected that the consistency of the existing product approval of the reshuffle effect should be the fastest in 2018 began to reflect.

It is understood that Nanjing to carry out the comprehensive management of hazardous chemicals, one of the important objectives is the full implementation of the “reduction” requirements, adjust and optimize the industrial structure, transformation and upgrading of traditional industries. Municipal Safety Supervision Bureau of the relevant person in charge, the comprehensive management of dangerous chemicals to strengthen the planning and layout, to enhance the industry access threshold, and actively promote the chemical industry, “shut down the transfer” work, standardize the management of chemical parks, chemical enterprises to enter the park Into the area. According to the plan, by 2020, the city of Nanjing chemical industry admission rate of more than 80%.

According to the requirements of comprehensive management program, the city will focus on promoting the optimization of chemical industry park layout; focus on the development of high-end production capacity, focusing on the development of large-scale integration of petrochemical, chemical new materials, high-end special chemicals, chemical energy and environmental protection and other four industries; Limit the excess capacity, make full use of industrial policy, safety, environmental protection, energy saving, price and other measures to guide the transfer of excess capacity and low-end capacity to exit; the location of the main function of the city does not meet the functional requirements and industrial layout requirements, Of the chemical industry to carry out the transformation, transfer, transformation or closure.

The comprehensive management of safety will also be combined with the “263″ special action “reduction” work requirements, the implementation of “one enterprise one policy”, clear shut down, transfer, upgrade and reorganization of work requirements, do not meet the local chemical industry development plan, Production technology and technical equipment behind, do not have the safety and environmental conditions of chemical companies, to be eliminated.

Crude oil bottomed out, with the capital level loose, chemical products spot synchronization appeared sharply higher. And large chemical trend is different from the cost and supply and demand expectations and other factors, plasticizers and raw materials this week did not follow the large chemical industry continues to be ascribed, and with the profit plate cash, part of the fundamentals to support the weaker products Even once appeared soft. The average price, the biggest increase this week, the product is octanol, the rest were +0.97%, +0.82% and -0.49%.

The following will be a detailed analysis of plasticizers and raw materials market performance this week.

O-benzene: benzene market this week, the overall focus has been higher. According to data monitoring, by the downstream just need to pick up the impact of the terminal ores spot inventory fell slightly to about 61,000 tons. From the level of the terminal inventory point of view, high inventory is still the main problem restricting the market, but the vast majority of the main source of factory supplies, the market can be accounted for less than the flow of concentrated and more concentrated, and thus still give the market a strong controllability. In the downstream just need to release, the market turnover improved, the overall focus on a small shift.

Phthalic anhydride: This week the domestic phthalic anhydride market high callback. Weekly, phthalic anhydride industry, the overall operating load is still low, the market stock supply situation has not been able to effectively alleviate the tension, and the commodity futures market rebound to boost the mentality of the industry, the factory to maintain a very high price, thus giving the market a strong stability. Into the second half of the week, with the downstream plasticizer weak callback, the market waiting to see the atmosphere gradually increased, but also greatly inhibited the market high turnover to follow up the situation in the downstream demand level back pressure, the market weak callback.

Octanol: this week the domestic octanol market big steady small move. This week the domestic scale production enterprises operating rate of 76.9%, the overall level of inventory is low. Zhou early octanol main factory factory price steady, because of its sales pressure is not, so very willing to price is strong. Raw material propylene fell slightly, the cost side to see empty mind, but the overall supply of the factory tight, supply side support is still good, the market long and short game. Near the weekend raw material propylene steady operation, Lubon device restart full load operation.

DOP: DOP market this week, weak weak, as of Friday, the East China market closed to 8000-8100 yuan / ton from the mention, the North market closed to 7850-8050 yuan / ton from the mention, the Guangdong market closed to 8250-8300 Yuan / ton sent around, the average weekly price fell 0.25%, of which North China led by 0.56%. Weekly market steady slightly lower, double raw material consolidation difficult to continue to provide support, the downstream demand layer began to lead the negative market demand, the downstream demand for follow-up downstream, under the pressure of large market prices began to loose, but given the Stage high cost pressure market decline is not big.

Next week forecast: the recent large chemical industry showed a strong short squeeze trend, which rose a larger plastic products. Due to plasticizers and raw materials, the fundamentals of the product fundamentals have emerged a greater degree of release, although the status of large chemical strength of its existence and repair costs and confidence, but the short term the market is also facing a greater degree of demand weakening pressure The Later, as the current round of large chemical rebound and the rebound can continue to continue, then the latter part of the plasticizer chain products are likely to be boosted, but if the expected rebound in large chemical market rebound, the plasticizer chain Will also face a greater risk of being dragged down.

International crude oil rose sharply rebounded, pure benzene market callback yesterday (May 22) domestic propylene market rose sharply, acetic acid ester solvent raw material prices, rising momentum is better. The domestic environmental emissions gradually become more stringent, the chemical plant operating rate is low, the market library low, the majority of domestic chemical raw materials rose.

International crude oil

Last week 19, the New York Mercantile Exchange, June delivery of light crude oil futures rose $ 0.98 to close at $ 50.33 a barrel, or 2.0% last week, international oil prices rose nearly 6%. In fact, since the end of this month on the 5th, the international oil prices have continued to rebound for two weeks, the cumulative increase rate of nearly 10%.

Pure benzene

May 19, the US benzene market FOB US Gulf rose 6 cents to 282-282.1 cents / gallon, equivalent to 846-846.3 US dollars / ton. Asian benzene market FOB Korea rose 31 US dollars to 788.5-789.5 US dollars / ton, FOB Southeast Asia rose 31 US dollars to 788.5-789.5 US dollars / ton, CFR China rose $ 30 to 803-804 US dollars / ton.
The following are the same as the ”

Last week, the domestic benzene market by the international crude oil and the international benzene market, a substantial rebound. However, because only the high order of styrene finishing momentum, the majority of other downstream products, the majority of weak loss state, therefore, this week the main domestic benzene stable stability.

Propylene

Today (May 22) propylene market prices began to rise sharply, of which the mainstream of Shandong market turnover 6950-7000 yuan / ton. Polypropylene powder profit is good, high enthusiasm for the procurement of propylene. The current refinery shipments are better, the inventory is low, and there is no shipping pressure.
The following are the same as the ”

Recent domestic refineries by environmental pressure, start limited, low inventory, demand is better, short-term market bullish.

Acrylic acid

Today (May 22) acrylic and ester market continued fried atmosphere, BASF announced its installation in the United States force majeure parking maintenance time to continue fermentation. At present the acrylic market inventory tension, in the state of no market price.
The following are the same as the ”

Today, the domestic market began to rise sharply, by environmental pressure, the refinery started low, low inventory, businesses began to reluctant to sell. Is expected to remain up in the short term momentum.

Butyl acrylate

Today, part of the production of butyl acetate in East China enterprises continue to pull up the offer price, a market supplier offer 8900-9000 yuan / ton, the real price to close to the offer price. Secondary market brokers inventory low, holding goods reluctant to sell.
The following are the same as the ”

Raw material propylene market prices continue to rise, the market positive attitude, plus polypropylene powder today hike, demand for propylene continues to increase. At present the market fried atmosphere rich, the recent environmental pressure, raw material support, suppliers dominate the market mostly short-term bullish.